Reports for SANDOZ CANADA INCORPORATED

Company Name
SANDOZ CANADA INCORPORATED

Shortage reports

Actual shortage:

46 (2%)

Anticipated shortage:

1 (0%)

Avoided shortage:

19 (1%)

Resolved:

2226 (97%)

2292

Discontinuation Reports

To be discontinued:

4 (3%)

Discontinued:

119 (95%)

Reversed:

2 (2%)

125

453 (19%)

14 (27%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
SANDOZ RIVASTIGMINE 3MG CAPSULE Resolved 2024-10-28 2024-12-11 241411
SANDOZ RIVASTIGMINE 6MG CAPSULE Resolved 2024-08-20 2024-12-11 235570
SANDOZ RIVASTIGMINE 1.5MG CAPSULE Resolved 2023-03-06 2023-04-05 186300
SANDOZ RIVASTIGMINE 3MG CAPSULE Resolved 2019-02-04 2019-04-10 74710
SANDOZ RIVASTIGMINE 3MG CAPSULE Resolved 2022-02-01 2022-03-11 154015
SANDOZ RIVASTIGMINE 3MG CAPSULE Resolved 2024-09-16 2024-12-11 237764
SANDOZ RIVASTIGMINE 3MG CAPSULE Resolved 2021-11-15 2021-12-20 149283
SANDOZ RIVASTIGMINE 4.5MG CAPSULE Resolved 2024-09-16 2024-12-11 237768
SANDOZ RIVASTIGMINE 1.5MG CAPSULE Resolved 2017-03-21 2017-05-17 3878
SANDOZ RIVASTIGMINE PATCH 10 9.5MG PATCH Resolved 2023-04-21 2023-06-07 190154
SANDOZ RIVASTIGMINE PATCH 10 9.5MG PATCH Resolved 2024-11-25 2024-12-03 243850
SANDOZ RIVASTIGMINE PATCH 10 9.5MG PATCH Resolved 2025-03-17 2025-04-01 252700
SANDOZ RIVASTIGMINE PATCH 10 9.5MG PATCH Resolved 2024-04-02 2024-05-01 224174
SANDOZ RIVASTIGMINE PATCH 5 4.6MG PATCH Resolved 2024-03-11 2024-04-16 221841
SANDOZ RIVASTIGMINE PATCH 5 4.6MG PATCH Resolved 2024-09-03 2024-12-03 236571
SANDOZ RIZATRIPTAN ODT 5MG TABLET (ORALLY DISINTEGRATING) Resolved 2025-01-13 2025-04-01 247620
SANDOZ RIZATRIPTAN ODT 10MG TABLET (ORALLY DISINTEGRATING) Resolved 2022-10-04 2022-10-20 171080
SANDOZ RIZATRIPTAN ODT 10MG TABLET (ORALLY DISINTEGRATING) Resolved 2025-03-10 2025-03-18 252241
SANDOZ RIZATRIPTAN ODT 5MG TABLET (ORALLY DISINTEGRATING) Resolved 2021-08-16 2021-09-21 144220
SANDOZ RIZATRIPTAN ODT 5MG TABLET (ORALLY DISINTEGRATING) Resolved 2025-05-05 2025-07-15 256673
Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ALFENTANIL INJECTION USP Discontinued 2019-10-15 2019-10-15 96610
ATRACURIUM BESYLATE INJECTION Discontinued 2019-10-15 2019-10-15 96613
BETAJECT Discontinued 2019-10-15 2019-10-15 96616
BLUE COLLYRIUM Discontinued 2019-10-15 2019-10-15 96619
BRETYLIUM TOSYLATE INJECTION USP Discontinued 2020-04-01 2020-04-01 110288
BRETYLIUM TOSYLATE INJECTION USP 50MG SOLUTION Discontinued 2017-12-06 2017-12-06 31958
CLINDAMYCIN INJECTION USP 150MG LIQUID Discontinued 2017-06-06 2017-10-18 12122
CODEINE PHOSPHATE INJECTION USP 30MG LIQUID Discontinued 2022-04-20 2022-04-20 159064
COMTAN 200MG TABLET Discontinued 2022-03-03 2022-03-04 155940
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Discontinued 2018-08-27 2019-01-02 59179
FOLIC ACID INJECTION USP 5MG LIQUID To be discontinued 2019-05-01 2019-05-01 82956
FOLIC ACID INJECTION USP 5MG LIQUID Discontinued 2020-01-28 2020-01-28 104481
HEPARIN SODIUM INJECTION USP (SINGLE USE VIAL-PRESERVATIVE FREE) 10000UNIT SOLUTION Discontinued 2018-07-04 2018-07-31 54349
HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE) 10000UNIT SOLUTION Discontinued 2024-05-17 2024-05-18 228249
HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE) 10000UNIT SOLUTION Discontinued 2023-10-18 2023-10-19 207275
IMIPENEM AND CILASTATIN FOR INJECTION USP 250MG 250MG POWDER FOR SOLUTION Discontinued 2021-08-23 2021-08-23 144467
KETOROLAC TROMETHAMINE INJECTION USP 30MG SOLUTION LIQUID Discontinued 2025-08-04 2025-08-05 264341
LORAZEPAM INJECTION USP 2MG SOLUTION Discontinued 2020-02-14 2020-03-12 106265
MICRO PLUS 6 (CONCENTRATE) 75MCG 60MCG 10MCG 0.5MG 1MG 5MG LIQUID Discontinued 2021-10-25 2021-10-26 147927
MILRINONE LACTATE INJECTION 1MG SOLUTION Discontinued 2022-06-17 2022-06-18 163000

Showing 1 to 20 of 125